VIASPACE Prepares to Seal Deal with Elite
Investing is hard enough, tries to simplify the whole process. Join our free email newsletter!
Under $0.25 Momentum Plays, One Of Many Features Available On Pro.
Try It Free For 14 Days!

VIASPACE Prepares to Seal Deal with Elite

Under $0.25 Momentum Plays, One Of Many Features Available On Pro.
Try It Free For 14 Days!
By: Dylan Sikes – News

Monday, February 11, 2019

VIASPACE, Inc. (OTC:VSPC) is getting the process of acquitting luxury cosmetics company Elite Therapeutics into high gear… a process dating back four years.

The Santa Cruz, Calif.-based VIASPACE had previously signed a non-binding Letter of Intent (LOI) to acquire Elite. In May 2015, the proposed acquisition was tabled to allow each company to focus on their respective core businesses. There are recent developments that now make this acquisition more compelling.

VIASPACE CEO Kevin Schewe said, “We are projecting that the acquisition of Elite Therapeutics will add more than $300,000 of revenue to VIASPACE in 2019 with plans to grow the luxury CBD cosmetic product line moving forward and create economies of scale through our partnership with Viaspace California, Inc.”

Elite Therapeutics was founded in 2007 as Bad Love Cosmetics Company, LLC and began doing business as Elite Therapeutics with high quality, results-driven, medical grade cosmetics in late 2010.

The excitement found its way to the investment floor, where shares in VSPC vaulted three-100ths of a cent, or 75%, to seven-100ths of a cent, on volume of 9.6 million shares.

Copyright © 2019 All rights reserved. Republication or redistribution of's content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Online Jeweller Looks Poised To Retest All-Time Highs
Supernova Buys Refinery, Shares Take Off for Stars
Clothier Launches Website, Investors Respond
CardioComm Announces New Product, Shares Climb

Back to Top